Clinical Trial Update: Neurobiology and Treatment of Reading Disability in NF-1 [NA]

View source ↗

Summary

This completed study investigates the neurobiological basis and treatment approaches for reading disability in Neurofibromatosis Type 1. The results have been p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslexia
• Neurofibromatosis Type

Snippet

Sponsor: Vanderbilt University | Conditions: Neurofibromatosis Type 1, Reading Disabilities | NA | Status: COMPLETED | Results posted: 2017-04-10